Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Research output: Contribution to journal › Article
|Journal||Journal of Clinical Oncology|
|Publication status||Published - 2005|
Select an option